Trials / Completed
CompletedNCT05019768
Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS
Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS: Results of a 2-year Randomized Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Ciro Caruso · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In the present study the investigators compare the clinical outcome corneal cross linking with either the stand-ard Dresden (sCXL) or the accelerated custom-fast (aCFXL) ultraviolet A irradiation protocol using riboflavin-D-α-Tocopheryl polyethyleneglycol1000 succinate for progressive keratoconus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | accelerated custom-fast CXL | The accelerated custom fast CXL (aCFXL) has been developed on a published mathematical model that takes into consideration objective variables such as the equation governing the UVA-induced riboflavin consumption rate and the corneal thickness at its thinnest point. By knowing both values, the mathematical model allows to objectively calculate both the exact UVA irradiation value (intensity), expressed in mW/cm2, and the irradiation time |
| OTHER | Standard CXL | The standard CXL procedure has been carried on following the Dresden protocol |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2021-08-25
- Last updated
- 2021-08-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05019768. Inclusion in this directory is not an endorsement.